Can merging MRI and ultrasound improve cancer treatment?
NCT ID NCT05977621
First seen Jan 11, 2026 · Last updated Jun 14, 2026 · Updated 21 times
Summary
This study explores whether combining MRI and ultrasound images can help doctors guide brachytherapy (internal radiation) more precisely for uterine cancer. Researchers will take ultrasound images of the pelvis and try to fuse them with existing MRI scans. The goal is to see if this fusion is possible and could lead to better needle placement during treatment. About 17 adults with uterine cancer who are scheduled for brachytherapy will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke Cancer Center
RECRUITINGDurham, North Carolina, 27710, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.